Resources available through the Global Health Vaccine Accelerator Platforms Portal
The Global Health Vaccine Accelerator Platform (GH-VAP) program provides investigators with access to several specialized research platforms to accelerate vaccine discovery and translation across infectious disease areas. Investigators access the GH-VAP platforms through a request, review and approval process via the GH-VAP web portal. Requests are evaluated based on scientific merit, alignment with BMGF strategic priorities and availability of resources. Approved requests trigger the development of a Material Transfer Agreement (MTA), Research Collaboration Agreement (RCA), and/or Statement of Work (SOW) between the investigator and the platform. These agreements can take 1-3 months to complete, so please allow adequate time when submitting your request.